38 results
8-K
EX-10.1
TXMD
TherapeuticsMD Inc
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
containing any Hazardous Material), including the movement of any Hazardous Material through the air, soil, surface water or groundwater
8-K
EX-10.1
TXMD
TherapeuticsMD Inc
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
Material through the air, soil, surface water or groundwater.
“Requirements of Law” means, with respect to any Person, collectively, the common law
8-K
EX-10.1
TXMD
TherapeuticsMD Inc
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
the movement of any Hazardous Material through the air, soil, surface water or groundwater.
“Requirements of Law” means, with respect to any Person
8-K
EX-10.2
xobjwuz
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-2.1
firda9x
31 May 22
TherapeuticsMD and EW Healthcare Partners
6:47am
8-K
EX-2.1
ojfg 6x2a9o
10 Mar 22
TherapeuticsMD Announces Fourth Quarter 2021 Financial Results
7:15am
S-3ASR
EX-1.2
lp05cbwslbpv
4 Mar 21
Automatic shelf registration
12:00am
8-K
EX-99.2
0b54sgv76 rro5vv1
2 Mar 21
TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results
7:00am
8-K
EX-1.1
lau9rjd320cqzav
16 Feb 21
Entry into a Material Definitive Agreement
8:35am
8-K
EX-99.1
jokkaw3y
13 Jan 21
Entry into a Material Definitive Agreement
8:50am
8-K
EX-1.1
30afga7b
27 Nov 20
Entry into a Material Definitive Agreement
4:35pm
8-K
EX-1.1
e8rrum
13 Nov 20
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
okel2
29 Oct 19
Entry into a Material Definitive Agreement
8:52am
8-K
EX-1.1
vi8 zaf7m
3 Aug 18
Entry into a Material Definitive Agreement
9:28am
8-K
EX-1.1
2t1va2c9
15 Jul 15
Entry into a Material Definitive Agreement
12:00am